Pharmacological studies in an herbal drug combination of St. John's Wort (Hypericum perforatum) and passion flower (Passiflora incarnata): In vitro and in vivo evidence of synergy between Hypericum and Passiflora in antidepressant pharmacological models

Fitoterapia

Volumn 82, Issue 3, 2011, Pages 474-480

  Fiebich, Bernd L ^a,b   Knörle, Rainer ^c   Appel, Kurt ^b   Kammler, Thomas ^d   Weiss, Gabriele ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b VIVACELL BIOTECHNOLOGY GMBH   (Germany)

^c IBAM GbR   (Germany)

^d Pascoe Pharmazeutische Praeparate GmbH Giessen   (Germany)

Author keywords

Forced swimming test; Hypericum; Mood disorders; Neurapas balance; Neuropharmacology; Passiflora; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; FLUVOXAMINE; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; NEURAPAS; PASSIFLORA INCARNATA EXTRACT; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; FORCED SWIMMING TEST; IC 50; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MONOTHERAPY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; SYNAPTOSOME;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOLOGICAL TRANSPORT; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HYPERICUM; PASSIFLORA; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SWIMMING; SYNAPSES;

HYPERICUM; HYPERICUM PERFORATUM; PASSIFLORA; PASSIFLORA INCARNATA; VALERIANA;

EID: 79951677322     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2010.12.006     Document Type: Article

References (40)

1. S.S. Chatterjee, M. Noldner, E. Koch, and C. Erdelmeier Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility Pharmacopsychiatry 31 Suppl 1 1998 7 15 (Pubitemid 28294220)
2. J. De Vry, S. Maurel, R. Schreiber, R. de Beun, and K.R. Jentzsch Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism Eur Neuropsychopharmacol 9 1999 461 468 (Pubitemid 30089057)
3. C. Gambarana, P.L. Tolu, F. Masi, M. Rinaldi, D. Giachetti, and P. Morazzoni A study of the antidepressant activity of Hypericum perforatum on animal models Pharmacopsychiatry 34 Suppl 1 2001 S42 S44
4. A.H. Burstein, R.L. Horton, T. Dunn, R.M. Alfaro, S.C. Piscitelli, and W. Theodore Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers Clin Pharmacol Ther 68 2000 605 612 (Pubitemid 32059986)
5. W.E. Muller, A. Singer, and M. Wonnemann Mechanism of action of St. Johns wort extract Praxis 89 2000 2111 2121 (Bern. 1994) (Pubitemid 32009429)
6. S. Caccia, and M. Gobbi St. John's wort components and the brain: uptake, concentrations reached and the mechanisms underlying pharmacological effects Curr Drug Metab 10 2009 1055 1065
7. V. Butterweck Mechanism of action of St John's wort in depression: what is known? CNS Drugs 17 2003 539 562 (Pubitemid 36774135)
8. K. Dhawan, S. Dhawan, and A. Sharma Passiflora: a review update J Ethnopharmacol 94 2004 1 23 (Pubitemid 38942830)
9. S. Oga, P.C. de Freitas, A.C. Gomes da Silva, and S. Hanada Pharmacological trials of crude extract of Passiflora alata Planta Med 50 1984 303 306 (Pubitemid 14008706)
10. R. Soulimani, C. Younos, S. Jarmouni, D. Bousta, R. Misslin, and F. Mortier Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse J Ethnopharmacol 57 1997 11 20 (Pubitemid 27303468)
11. E. Speroni, and A. Minghetti Neuropharmacological activity of extracts from Passiflora incarnata Planta Med 54 1988 488 491 (Pubitemid 19007988)
12. S.M. Elsas, D.J. Rossi, J. Raber, G. White, C.A. Seeley, and W.L. Gregory Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method Phytomedicine 17 12 2010 940 949
13. E. Ernst Herbal remedies for anxiety-a systematic review of controlled clinical trials Phytomedicine 13 2006 205 208 (Pubitemid 43120323)
14. S. Akhondzadeh, H.R. Naghavi, M. Vazirian, A. Shayeganpour, H. Rashidi, and M. Khani Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam J Clin Pharm Ther 26 2001 363 367 (Pubitemid 32989558)
15. E. Brown, N.S. Hurd, S. McCall, and T.E. Ceremuga Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat AANA J 75 2007 333 337 (Pubitemid 47584175)
16. C. Wolfman, H. Viola, A. Paladini, F. Dajas, and J.H. Medina Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea Pharmacol Biochem Behav 47 1994 1 4
17. A. Gramowski, K. Jugelt, S. Stuwe, R. Schulze, G.P. McGregor, and A. Wartenberg-Demand Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochips Eur J Neurosci 24 2006 455 465 (Pubitemid 44100337)
18. E. Kommission Monographie Hyperici herba (Johanniskraut) Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) 1989
19. E. Kommission Monographie Passiflorae herba (Passionsblumenkraut) Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) 1990
20. E. Kommission Monographie Valerianae radix (Baldrianwurzel) Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) 1990
21. D.J. Nutt, and D.J. Stein Understanding the neurobiology of comorbidity in anxiety disorders CNS Spectr 11 2006 13 20 (Pubitemid 44625550)
22. G.P. McGregor Kombination von Johanniskraut-, Baldrian- und Passionsblumen-Extrakten in einem pflanzlichen Arzneimittel Arztezeitschrift Naturheilverfahren 43 2002 348 353 (Pubitemid 34685770)
23. P. Pacher, and V. Kecskemeti Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Curr Med Chem 11 2004 925 943 (Pubitemid 38425924)
24. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioural despair in rats: a new model sensitive to antidepressant treatments Eur J Pharmacol 47 1978 379 391
25. A. Singer, M. Wonnemann, and W.E. Muller Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na + 1 J Pharmacol Exp Ther 290 1999 1363 1368 (Pubitemid 29400281)
26. K. Lieb, B.L. Fiebich, I. Herpfer, M. Mantovani, M. Loffler, and T.J. Feuerstein No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes Eur Neuropsychopharmacol 15 2005 641 646 (Pubitemid 41587415)
27. V. Butterweck, V. Christoffel, A. Nahrstedt, F. Petereit, B. Spengler, and H. Winterhoff Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models Life Sci 73 2003 627 639 (Pubitemid 36589040)
28. L. Iversen Neurotransmitter transporters and their impact on the development of psychopharmacology Br J Pharmacol 147 Suppl 1 2006 S82 S88
29. W.E. Muller Current St John's wort research from mode of action to clinical efficacy Pharmacol Res 47 2003 101 109 (Pubitemid 36263444)
30. R. Madabushi, B. Frank, B. Drewelow, H. Derendorf, and V. Butterweck Hyperforin in St. John's wort drug interactions Eur J Clin Pharmacol 62 2006 225 233 (Pubitemid 43357581)
31. H.C. Orth, C. Rentel, and P.C. Schmidt Isolation, purity analysis and stability of hyperforin as a standard material from Hypericum perforatum L J Pharm Pharmacol 51 1999 193 200 (Pubitemid 29131313)
32. V. Butterweck, G. Jurgenliemk, A. Nahrstedt, and H. Winterhoff Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test Planta Med 66 2000 3 6 (Pubitemid 30097270)
33. O. Grundmann, C. Wahling, C. Staiger, and V. Butterweck Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice Pharmazie 64 2009 63 64
34. P.R. Barbosa, S.S. Valvassori, C.L. Bordignon Jr., V.D. Kappel, M.R. Martins, and E.C. Gavioli The aqueous extracts of Passiflora alata and Passiflora edulis reduce anxiety-related behaviors without affecting memory process in rats J Med Food 11 2008 282 288 (Pubitemid 351948187)
35. P.C. de Castro, A. Hoshino, J.C. da Silva, and F.R. Mendes Possible anxiolytic effect of two extracts of Passiflora quadrangularis L. in experimental models Phytother Res 21 2007 481 484 (Pubitemid 46715092)
36. O. Grundmann, J. Wang, G.P. McGregor, and V. Butterweck Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system Planta Med 74 2008 1769 1773
37. L.F. Lolli, C.M. Sato, C.V. Romanini, L.B. Villas-Boas, C.A. Santos, and R.M. de Oliveira Possible involvement of GABA A-benzodiazepine receptor in the anxiolytic-like effect induced by Passiflora actinia extracts in mice J Ethnopharmacol 111 2007 308 314 (Pubitemid 46553717)
38. K. Linde, M.M. Berner, and L. Kriston St John's wort for major depression, Cochrane Database Syst Rev 2008 CD000448
39. H. Zhong, K.B. Hansen, N.J. Boyle, K. Han, G. Muske, and X. Huang An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant Neurosci Lett 462 2009 207 212
40. L.D. Jayanthi, and S. Ramamoorthy Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants AAPS J 7 2005 E728 E738